Bill Wilson, MD: Harnessing Biomarkers & Empirical Science to Unravel Disease & Detect Cancer Early
Short excerpt from a YouTube interview (Dr. Ron Najafi interviewing Bill Wilson, MD) emphasizing the importance of detecting disease at early stages (stage one vs stage four) to enable more effective interventions. Pancreatic cancer is cited as an example that often presents late; the speakers highlight ongoing work on blood-based biomarkers and the value of collaboration between biochemical researchers and empirical scientists.
More from Dr.
Hippocrates said, let thy food be thy medicine #obesity #metabolicsyndrome #lustig #shorts #health
Bill Wilson, MD: Why GLP-1 Drugs Are Overpriced—and How Compounding and Competition Could Fix It
Nitrosamine in Pharmaceutical Products? A Deep Dive into Risk Management by Ron Najafi, Ph.D.
The Subcellular Processes That Belie All Chronic Disease. The Hateful (or Grateful) Eight #lustig
Bill Wilson, MD: GLPs May Reverse Carb Syndrome—Helping Patients Reach Zero and Sustain with Diet
Why Everything You Knew About Obesity Is Wrong | Dr. Robert Lustig on Sugar & Metabolic Syndrome
Robert Lustig, MD: How Fructose Fuels Fatty Liver, Oxidative Stress, and Metabolic Disease #fructose
Robert Lustig, MD: The 3 Types of Fat Fueling Insulin Resistance and Disease #insulin resistance
Bill Wilson, MD: GLPs May Reverse CARB Syndrome. Helping Patients Reach Zero and Sustain with Diet